Online Behavioral Obesity Treatment for Obesity
(FUEL Trial)
Trial Summary
Do I need to stop my current medications for this trial?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently taking weight loss medication.
What data supports the effectiveness of the Online Behavioral Obesity Treatment for weight loss?
Research shows that online behavioral obesity treatments can help people lose 4-7 kg (about 9-15 pounds) over 6 months to a year when support is provided through email, automated messages, or chat rooms. These programs have been shown to be effective in helping people lose weight and maintain it over time.12345
Is online behavioral obesity treatment safe for humans?
How is the Gold-Standard Online Behavioral Obesity Treatment different from other obesity treatments?
The Gold-Standard Online Behavioral Obesity Treatment is unique because it is delivered entirely online, making it more accessible and potentially more engaging with features like interactive websites and counselor contact. It focuses on behavioral changes to support weight loss and is designed to be cost-effective, aiming to maximize weight loss for less than $500.12678
What is the purpose of this trial?
This project seeks to better understand dietary lapses (instances of nonadherence to dietary goals), a major cause of poor outcomes during behavioral obesity treatment (BOT). Investigators propose to conduct multimodal real-time assessment of behavioral, psychosocial, and contextual characteristics to uncover lapse phenotypes (i.e., meaningful clusters of lapse behaviors, such as lapsing via overeating vs. lapsing via eating an off-plan food). Using wearable sensors and a smartphone-based assessment platform, this research will identify latent characteristics underlying different phenotypes of dietary lapses reported by individuals who are participating in an online BOT. This study will also evaluate how these emerging lapse phenotypes vary over time, between individuals, and within individuals. Such information will ultimately help the field understand how best to reduce lapses in future treatments (e.g., how much to personalize future interventions for lapse vs. generalizability of lapse phenotypes across individuals). Therefore, this study has three goals. First, investigators aim to establish lapse phenotypes by identifying clusters of behavioral, psychosocial, contextual and individual-level factors (e.g., sex, race) that differentiate lapse behaviors during weight loss and maintenance. Second, the investigators aim to test the association of lapse phenotypes with energy intake and weight change during weight loss and maintenance to determine which lapse phenotypes have the greatest impact on BOT outcomes (e.g. personal, environmental, and behavioral factors). Lastly, investigators aim to evaluate individual variability in the occurrence of lapse phenotypes during weight loss and maintenance to determine the generalizability of lapse phenotypes across individuals.Participants will be recruited through various methods including advertisements in local media, targeted online advertising, advertisements in medical and minority communities, and direct mailers. All participants will receive a well-established online BOT program for 12 months, with a 6-month maintenance period, for a total study participation of 18 months. In conjunction, they will complete 14-day monitoring periods (at baseline, 3 months, 6 months, 12 months, and 18 months) consisting of: 1) repeated daily smartphone surveys to assess personal, environmental, and behavioral factors, including automatic capture of geographic location; 2) wearing two wrist-based sensor devices to passively capture physical activity, sleep, and eating behaviors; and 3) completing telephone-based 24-hour dietary recalls to assess overall energy intake. Weight will be measured at all visits to the research center.
Eligibility Criteria
The FUEL trial is for adults aged 18-70 with a BMI between 25 and 50, who haven't lost more than 5% of their body weight recently, aren't on weight loss meds, not pregnant or breastfeeding, and haven't had weight loss surgery or an eating disorder (except Binge Eating Disorder).Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline questionnaires and a 1-week behavioral run-in with smartphone-based surveys and sensor wear
Treatment
Participants receive a 12-month online behavioral obesity treatment program
Maintenance
Participants undergo a 6-month no-treatment follow-up period intended for weight maintenance
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Gold-Standard Online Behavioral Obesity Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Miriam Hospital
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator